Načítá se...
Bradycardia After Intravenous Ondansetron with Asystole on Rechallenge: A Case Report
PURPOSE: There have been 3 published reports (4 cases) of symptomatic sinus bradycardia occurring after intravenous (IV) administration of the selective 5-hydroxytryptamine 3 (5-HT(3)) receptor antagonist ondansetron. We report a fifth case in which the patient developed asystole after rechallenge w...
Uloženo v:
| Vydáno v: | Hosp Pharm |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Thomas Land Publishers, Inc.
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5057199/ https://ncbi.nlm.nih.gov/pubmed/27729680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1310/hpj5010-918 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|